trial

Neuroendocrine and Immune Response to Stress in Schizophrenia

NCTId NCT01975584
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 21 (actual)
Sponsored by University of Maryland, Baltimore County
Primary completion 2018-06
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
21 (actual)
Study type
Interventional
Allocation
Na
Model
Single Group
Masking
None
Start
2013-09
Primary completion
2018-06
Eligibility
ALL · 18 Years · 64 Years

Interventions & indications

Drugs
Trier Social Stress Test

Sponsors

University of Maryland, Baltimore CountyLead Sponsor

Investigators

1
Deanna L. Kelly, Pharm.D., BCPPPrincipal Investigator

Sites

1 total
Catonsville, United States

Facts & assertions

4 sourced
Enrollment
21
Phase
NA
Primary Completion Date
2018-06
Status
COMPLETED
relationships
The graph out of here
drug
Trier Social Stress Test
drug
lead_sponsor
University of Maryland, Baltimore County
company
indication
Schizophrenia
indication
Schizoaffective Disorder
indication
Schizophrenia
indication
investigator
Deanna L. Kelly, Pharm.D., BCPP
person